Canaccord Genuity reiterated a Hold rating on Meridian Biosciences (NASDAQ: VIVO), and cut the price target to $19.00 (from $20.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Meridian Bioscience (VIVO) Declares $0.20 Quarterly Dividend; 4.1% YieldJuly 23, 2015 8:26 AM Meridian Bioscience (VIVO) Reports In-Line Q2 EPSJuly 23, 2015 8:26 AM Meridian Bioscience Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2015 GuidanceJuly 23, 2015 8:00 AM